Whoop

Whoop just closed one $575 million Series G which values ​​it at 10,000 million. Among its new investors there are profiles that contextualize this company well: the Mayo Clinic, the sovereign fund of Qatar, LeBron James and Cristiano Ronaldo. Capital, health and sports. Quite a declaration of intent about what market Whoop is serious about. Between the lines. The market for elite athletes has never been worth $10 billion. Whoop knows this and that’s why it has been transforming for years: hired its first medical director in 2022obtained authorization from the US FDA to record electrocardiograms, integrated blood test analysis (forgive the redundancy) into its platform and has gone from selling bracelets to selling subscriptions of between $149 and $359 a year that combine hardware with health services. The bracelet is the hook. The personal health platform is the business. And it’s getting clearer. The money trail. With 2.5 million active subscribers and reserves that exceeded $1 billion in 2025, doubling those of the previous year, Whoop was not in any financial emergency, it did not need this money to survive. It needs it to scale: the 575 million will finance an international expansion throughout Europe, Latin America, Asia and the Persian Gulf, and will almost double its current workforce of 800 people with 600 new hires. The logic is that of any subscription company that has found a fit between its product and the market: grow before someone else does. Yes, but. The road is full of corpses. In recent years we have seen the birth, growth and fall of Pebbleto Jawboneto fitbitalso to other examples of independent hardware beyond health, such as Human AI either Magic Leap: The consumer hardware sector has destroyed capital with remarkable efficiency. And Whoop doesn’t play in a quiet niche: the Apple Watch is the wearables best seller in the world and includes increasingly advanced health functions, Xiaomi and Huawei are breathing down your neck, and Google still has Fitbit although Your future only passes through the Pixel Watch. Additionally, Whoop cannot yet compete with the sports market that requires a screen to view exercise tracking (Garmin, Suunto, Coros, etc). Competing against companies with ecosystems of billions of users and enormous balance sheets is a peculiar gamble for a Boston startup, no matter how well funded it is. But no one can take away from him what he has achieved so far, which is a lot. The big question. Whoop’s answer to that problem is the same as any company that can’t win on generic hardware: specialize until comparison is impossible. His recent integration with Soaak Technologieswhich uses the bracelet’s real-time physiological data to adjust sound frequency compositions to the user’s state, points in that direction: building a third-party ecosystem that makes switching platforms increasingly expensive. The goal is not to be the best-selling bracelet, that is a lost war. It is being the health platform to which the most things are connected. Go deeper. An IPO is on the table. In November, its founder, Will Ahmed, spoke about the possibility of this operation over a two-year horizon. With 575 million fresh in, Whoop can afford to wait for the right time, wait for a quieter time than this warlike spring of 2026, and show up when it has more users, more recurring revenue, and a fuller story to tell. The question is not whether it will go public. It will come out. It’s whether the market will continue to believe in those 10 billion when that time comes. In Xataka | The Nike Mind 001 are the strangest shoes I have ever tried. And that is precisely why they are being sold Featured image | Whoop